EICHOR
● Recruiting
Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis
Condition: Knee Osteoarthritis · Sponsor: Wuxi Cellular Biopharmaceutical Group Ltd.
About this study
Evaluate the efficacy and safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cells Therapy
This description comes directly from the study's public registry record.
Talk to the study team
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
Locations (2)
| RenJi Hospital | Shanghai, China, China | Recruiting |
| Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine | Shanghai, China | Not Yet Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06570291